niacinamide has been researched along with Hormone-Dependent Neoplasms in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a dose-escalation study to investigate the safety of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer (mCRPC)." | 2.77 | Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer. ( Canon, JL; Clausse, M; D'Hondt, L; Duck, L; Kerger, J; Machiels, JP; Mardjuadi, F; Medioni, J; Moxhon, A; Musuamba, F; Oudard, S, 2012) |
| "Sorafenib 400 mg was administered orally twice daily continuously." | 2.73 | A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. ( Chi, KN; Czaykowski, P; Ellard, SL; Gauthier, I; Hansen, C; Hotte, SJ; Moore, M; Ruether, JD; Schell, AJ; Seymour, L; Taylor, S; Walsh, W, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mardjuadi, F | 1 |
| Medioni, J | 1 |
| Kerger, J | 1 |
| D'Hondt, L | 1 |
| Canon, JL | 1 |
| Duck, L | 1 |
| Musuamba, F | 1 |
| Oudard, S | 1 |
| Clausse, M | 1 |
| Moxhon, A | 1 |
| Machiels, JP | 1 |
| Chi, KN | 1 |
| Ellard, SL | 1 |
| Hotte, SJ | 1 |
| Czaykowski, P | 1 |
| Moore, M | 1 |
| Ruether, JD | 1 |
| Schell, AJ | 1 |
| Taylor, S | 1 |
| Hansen, C | 1 |
| Gauthier, I | 1 |
| Walsh, W | 1 |
| Seymour, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study Of BAY 43-9006 (NSC 724772; CTEP IND# 69,896) In Patients With Hormone Refractory Prostate Cancer[NCT00093457] | Phase 2 | 28 participants (Actual) | Interventional | 2004-08-10 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for niacinamide and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; D | 2012 |
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Antin | 2008 |